Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Highbridge Capital Management
Quarter-by-quarter ownership of Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Highbridge Capital Management
from 13F filings
Historical chart of Highbridge Capital Management investment in Karyopharm Therapeutics Inc note 3.000%10/1
Tip: Access up to 7 years of quarterly data
All positions including Karyopharm Therapeutics Inc note 3.000%10/1 held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Karyopharm Therapeutics Inc note 3.000%10/1 by Highbridge Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $16B | 32M | 505.00 |
| 2023-09-30 | $21M | 31M | 0.68 |
| 2023-06-30 | $21M | 31M | 0.68 |
| 2023-03-31 | $22M | 29M | 0.76 |
| 2022-12-31 | $23M | 29M | 0.79 |
| 2022-06-30 | $23M | 31M | 0.73 |
| 2022-03-31 | $24M | 31M | 0.78 |
More positions owned by Highbridge Capital Management
View all positions for Highbridge Capital Management
Top funds holding Karyopharm Therapeutics Inc note 3.000%10/1
View all funds holding Karyopharm Therapeutics Inc note 3.000%10/1